These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5784248)

  • 21. [Migraine].
    Martínez Lage JM; Rodríguez y MC; Vázquez C
    Neurologia; 1996 Jan; 11(1):20-31. PubMed ID: 8714172
    [No Abstract]   [Full Text] [Related]  

  • 22. The antimigraine effect of ergotamine: a role for alpha-adrenergic blockade?
    Bonuso S; Di Stasio E; Marano E; Covelli V; Testa N; Tetto A; Buscaino GA
    Acta Neurol (Napoli); 1994; 16(1-2):1-10. PubMed ID: 8073910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study.
    Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
    Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):41-7. PubMed ID: 14971122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. To break the cycle of menstrual migraine.
    Jones JM
    JAAPA; 1999 Feb; 12(2):44-50, 57-8. PubMed ID: 10728067
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy and prophylaxis of migraine].
    Hoffmann J; Reuter U
    MMW Fortschr Med; 2009 Apr; 151(14):114-7; quiz 118. PubMed ID: 19504851
    [No Abstract]   [Full Text] [Related]  

  • 26. How I manage migraine.
    Lewis RH
    Aust Fam Physician; 1981 Aug; 10(8):602-3. PubMed ID: 7028014
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of Raynaud's phenomenon in patients with migraine.
    Zahavi I; Chagnac A; Hering R; Davidovich S; Kuritzky A
    Arch Intern Med; 1984 Apr; 144(4):742-4. PubMed ID: 6143540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of migraine].
    Ala-Hurula VM
    Duodecim; 1984; 100(4):230-4. PubMed ID: 6714111
    [No Abstract]   [Full Text] [Related]  

  • 29. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migraine: a pharmacologic review with newer options and delivery modalities.
    Baumel B
    Neurology; 1994 May; 44(5 Suppl 3):S13-7. PubMed ID: 7911231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of ischemic complications related to the intensity of triptan and ergotamine use.
    Wammes-van der Heijden EA; Rahimtoola H; Leufkens HG; Tijssen CC; Egberts AC
    Neurology; 2006 Oct; 67(7):1128-34. PubMed ID: 17030745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacotherapy of headache with special reference to migraine].
    Beubler E
    Wien Med Wochenschr; 1994; 144(5-6):100-1. PubMed ID: 8053212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenetic, clinical, electroencephalographic, and therapeutic study of migraine].
    Moraitis M; Kranidiotis P; Marki-Loukatou M; Terentios E; Tassiopoulou A; Monopolis S
    Med Monatsschr; 1972 Oct; 26(10):479-83. PubMed ID: 4647533
    [No Abstract]   [Full Text] [Related]  

  • 34. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experience with sumatriptan ++ in the treatment of migraine symptoms].
    Pascual J
    Neurologia; 1994; 9(7):282-6. PubMed ID: 7946423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Migraine treatment].
    Noth J
    Dtsch Med Wochenschr; 2000 Mar; 125(13):408. PubMed ID: 10778403
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment choices and patterns in migraine patients with and without a cardiovascular risk profile.
    Wammes-van der Heijden EA; Tijssen CC; Egberts AC
    Cephalalgia; 2009 Mar; 29(3):322-30. PubMed ID: 19220314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trial of a serotonin inhibitor BC 105 in the prevention of migraine.
    Hornabrook RW; Arthur G
    N Z Med J; 1969 Dec; 70(451):387-90. PubMed ID: 4392184
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complications in the treatment of migraine with ergotamine and its derivatives].
    Durko A; Głuszcz-Zielińska A
    Wiad Lek; 1981 May; 34(9):779-83. PubMed ID: 7281680
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale.
    Raskin NH
    Neurology; 1993 Jun; 43(6 Suppl 3):S39-42. PubMed ID: 8389010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.